{
    "nct_id": "NCT06848348",
    "official_title": "A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain",
    "inclusion_criteria": "* Male or female patients aged â‰¥18 years.\n* Neuropathic pain has been present and is attributed to platinum and/or taxane chemotherapy.\n* Patient has received a cancer chemotherapy regimen that included taxanes and/or platinum and has no active or discernible disease progression.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Current neuropathic pain with symptoms similar to CINP but attributed to causes other than platinum or taxane chemotherapy.\n* Patients who have received HAL at any time prior to screening.",
    "miscellaneous_criteria": ""
}